SARA RAPOSO: Open Payments
NPI 1629513684 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 41 payments from 9 companies in 2025. Trend: 2023 $256 · 2024 $448 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $268 |
| Vanda Pharmaceuticals Inc. | 7 | $144 |
| ABBVIE INC. | 4 | $88 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Alkermes, Inc. | 1 | $21 |
Products named: REXULTI, FANAPT, VRAYLAR, Qelbree, CAPLYTA, Auvelity, Jornay PM, SPRAVATO.
Industry payments across MA — which companies pay providers there.
